 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 21.65 |
1.12 % |
$ 1.01 B |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Aptorum Group Limited
APM
|
20.6 |
$ 0.9 |
-0.18 % |
$ 6.62 M |
China |
 |
ACADIA Pharmaceuticals
ACAD
|
37.5 |
$ 22.3 |
1.55 % |
$ 3.7 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Heron Therapeutics
HRTX
|
198 |
- |
- |
$ 198 M |
USA |
 |
ImmuCell Corporation
ICCC
|
47.5 |
$ 8.25 |
-1.26 % |
$ 74.5 M |
USA |
 |
Jaguar Health
JAGX
|
48.3 |
$ 0.28 |
-27.77 % |
$ 653 K |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aravive
ARAV
|
16.8 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
KalVista Pharmaceuticals
KALV
|
9.64 |
$ 19.16 |
-2.39 % |
$ 1.03 B |
Britain |
 |
Aridis Pharmaceuticals
ARDS
|
59 |
- |
17.91 % |
$ 11.1 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Aquestive Therapeutics
AQST
|
103 |
$ 4.1 |
0.49 % |
$ 438 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 |
$ 23.42 |
0.69 % |
$ 2.98 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Autolus Therapeutics plc
AUTL
|
58.2 |
$ 1.42 |
-1.39 % |
$ 378 M |
Britain |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 |
$ 241.79 |
4.55 % |
$ 4.42 B |
USA |
 |
Eli Lilly and Company
LLY
|
80.5 |
- |
- |
$ 783 B |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 |
$ 2.92 |
0.34 % |
$ 4.81 M |
Israel |
 |
Esperion Therapeutics
ESPR
|
99.7 |
- |
- |
$ 399 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |